Milestone Scientific announced receipt of multiple Notices of Allowance, NOA, for essential patent applications in both the U.S. and Europe. One NOA was granted by the U.S. Patent and Trademark Office and one NOA was granted by the European Patent Office for a new patent titled “Device and Method for Needle/Catheter Location Utilizing Correlation Analysis.” These patent applications cover Milestone Scientific’s next-generation Dynamic Pressure Sensing technology for real-time pressure-sensing guidance in manual injection systems. The innovative DPS technology enables fluid-pressure analysis to compare pressure signals, alert pressure thresholds, and display pressure graphs, in order to ensure accurate positioning of needles and catheters, as well as enhance the safety and precision of manual injections.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLSS:
- Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
- Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
- Milestone Scientific announces Medicare price assignment for CompuFlo
- Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida
- Milestone Scientific’s CompuFlo Epidural received favorable Medicare pricing
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue